They balance the public health benefits of keeping the population safe — and in school — with the need to maintain a strong economy to support all the residents of our state.
AI and Reddit are helping us track COVID-19's impact on mental health
It may be a ‘triumph of science,’ but still a long way to go
Pharma companies have had to adapt to a rare impediment—having to carry out their work on the disease while it’s all around them
No specific treatment or medication exists to treat anosmia. And yet, a patient's brain can be trained to accelerate the recovery of the lost sense of smell.
Textual analysis of social media posts finds users’ anxiety and suicide-risk levels are rising, among other negative trends.
Researchers turn to familiar model animals, along with some fresh strategies, to develop countermeasures against SARS-CoV-2 and investigate the biology of infection.
A new research is hoping to nip a COVID-19 infection in the bud before it progresses. (WJAR)
Beth Israel doctor on Mass. new COVID-19 directives
How Much Will It Cost To Get the Coronavirus Vaccine?
While daily case counts above 1,000 across the state are concerning, Beth Israel's chief nursing officer said that the increase in hospitalizations has been more gradual this time around
Moderna: 'We're Ready' To Ship 20 Million Coronavirus Vaccine Doses By The End Of 2020
Trial begins of at-home treatment that may keep early cases from growing severe
Dining out is one of the riskiest things you can do—but it doesn’t have to be, if you follow these steps.
Covid-19 vaccine trials from AstraZeneca, Johnson & Johnson to restart
In this opinion article, the author references a study released earlier in the year led by Dhruv Kazi, MD, MSc, MS (Cardiology, BIDMC) that quantified the effect of the COVID-19 pandemic on the numbers of patients seeking medical attention for select potentially life-threatening diagnoses.
Dan Barouch, MD, PhD (Center for Virology and Vaccine Research, BIDMC) discusses COVID-19 vaccine development.
Dan Barouch, MD, PhD (Center for Virology and Vaccine Research, BIDMC) was elected to the National Academy of Medicine for being an international leader in virology and immunology, developing novel vaccines and cure strategies for viruses of global importance, including one of the first COVID-19 vaccine candidates, the first Zika virus vaccine, and the first global mosaic HIV-1 vaccine, as well as defining immunotherapeutic HIV-1 cure strategies.
Two of the Boston area’s top experts (and parents) weigh in.
